892 related articles for article (PubMed ID: 25118781)
1. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics.
Magro CM; Abraham RM; Guo R; Li S; Wang X; Proper S; Crowson AN; Mihm M
Eur J Dermatol; 2014; 24(5):594-602. PubMed ID: 25118781
[TBL] [Abstract][Full Text] [Related]
2. The dermal-based borderline melanocytic tumor: a categorical approach.
Magro CM; Crowson AN; Mihm MC; Gupta K; Walker MJ; Solomon G
J Am Acad Dermatol; 2010 Mar; 62(3):469-79. PubMed ID: 20159313
[TBL] [Abstract][Full Text] [Related]
3. The correlation of the standard 5 probe FISH assay with melanocytic tumors of uncertain malignant potential.
Muhlbauer A; Momtahen S; Mihm MC; Wang J; Magro CM
Ann Diagn Pathol; 2017 Jun; 28():30-36. PubMed ID: 28648937
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence in situ hybridization (FISH) analysis of melanocytic nevi and melanomas: sensitivity, specificity, and lack of association with sentinel node status.
Fang Y; Dusza S; Jhanwar S; Busam KJ
Int J Surg Pathol; 2012 Oct; 20(5):434-40. PubMed ID: 22561674
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi.
Gerami P; Wass A; Mafee M; Fang Y; Pulitzer MP; Busam KJ
Am J Surg Pathol; 2009 Dec; 33(12):1783-8. PubMed ID: 19809275
[TBL] [Abstract][Full Text] [Related]
6. β-Catenin nuclear expression discriminates deep penetrating nevi from other cutaneous melanocytic tumors.
de la Fouchardière A; Caillot C; Jacquemus J; Durieux E; Houlier A; Haddad V; Pissaloux D
Virchows Arch; 2019 May; 474(5):539-550. PubMed ID: 30756182
[TBL] [Abstract][Full Text] [Related]
7. Histologically ambiguous ("borderline") primary cutaneous melanocytic tumors: approaches to patient management including the roles of molecular testing and sentinel lymph node biopsy.
Scolyer RA; Murali R; McCarthy SW; Thompson JF
Arch Pathol Lab Med; 2010 Dec; 134(12):1770-7. PubMed ID: 21128774
[TBL] [Abstract][Full Text] [Related]
8. Morphologic clues and utility of fluorescence in situ hybridization for the diagnosis of nevoid melanoma.
Yélamos O; Busam KJ; Lee C; Meldi Sholl L; Amin SM; Merkel EA; Obregon R; Guitart J; Gerami P
J Cutan Pathol; 2015 Nov; 42(11):796-806. PubMed ID: 26356543
[TBL] [Abstract][Full Text] [Related]
9. The plexiform spindle cell nevus nevi and atypical variants: report of 128 cases.
Hung T; Yang A; Mihm MC; Barnhill RL
Hum Pathol; 2014 Dec; 45(12):2369-78. PubMed ID: 25300464
[TBL] [Abstract][Full Text] [Related]
10. The role of lymphatic mapping and sentinel node biopsy in the management of atypical and anomalous melanocytic lesions.
Cochran AJ; Binder S; Morton DL
J Cutan Pathol; 2010 Apr; 37 Suppl 1():54-9. PubMed ID: 20482676
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence in situ hybridization as an ancillary tool in the diagnosis of ambiguous melanocytic neoplasms: a review of 804 cases.
North JP; Garrido MC; Kolaitis NA; LeBoit PE; McCalmont TH; Bastian BC
Am J Surg Pathol; 2014 Jun; 38(6):824-31. PubMed ID: 24618603
[TBL] [Abstract][Full Text] [Related]
12. Polypoid Compound Melanocytic Proliferations: A Clinicopathological Study.
Mesbah Ardakani N; Harvey NT; Wood BA
Am J Dermatopathol; 2019 Aug; 41(8):578-584. PubMed ID: 31335410
[TBL] [Abstract][Full Text] [Related]
13. Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumors.
Al-Rohil RN; Curry JL; Torres-Cabala CA; Nagarajan P; Ivan D; Aung PP; Lyons GF; Bassett RL; Prieto VG; Tetzlaff MT
Hum Pathol; 2016 Jul; 53():73-81. PubMed ID: 27004944
[TBL] [Abstract][Full Text] [Related]
14. Two congenital cases of pigmented epithelioid melanocytoma studied by fluorescent in situ hybridization for melanocytic tumors: case reports and review of these recent topics.
Battistella M; Prochazkova-Carlotti M; Berrebi D; Bennaceur S; Edan C; Riffaud L; Rütten A; Fraitag S
Dermatology; 2010; 221(2):97-106. PubMed ID: 20558976
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node biopsy for melanoma and other melanocytic tumors in adolescents.
Roaten JB; Partrick DA; Pearlman N; Gonzalez RJ; Gonzalez R; McCarter MD
J Pediatr Surg; 2005 Jan; 40(1):232-5. PubMed ID: 15868590
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node biopsy in histologically ambiguous melanocytic tumors with spitzoid features (so-called atypical spitzoid tumors).
Murali R; Sharma RN; Thompson JF; Stretch JR; Lee CS; McCarthy SW; Scolyer RA
Ann Surg Oncol; 2008 Jan; 15(1):302-9. PubMed ID: 18000712
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous regression of multiple melanocytic nevi after melanoma: report of 3 cases.
Martín JM; Pinazo I; Monteagudo C; Markovic J; Allende A; Jordá E
Am J Dermatopathol; 2014 Nov; 36(11):e183-8. PubMed ID: 25343215
[TBL] [Abstract][Full Text] [Related]
18. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.
Clark WH; Elder DE; Guerry D; Epstein MN; Greene MH; Van Horn M
Hum Pathol; 1984 Dec; 15(12):1147-65. PubMed ID: 6500548
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence in situ hybridisation (FISH) in histologically challenging conjunctival melanocytic lesions.
Mudhar HS; Smith K; Talley P; Whitworth A; Atkey N; Rennie IG
Br J Ophthalmol; 2013 Jan; 97(1):40-6. PubMed ID: 23137666
[TBL] [Abstract][Full Text] [Related]
20. Copy number variations and clinical outcome in atypical spitz tumors.
Raskin L; Ludgate M; Iyer RK; Ackley TE; Bradford CR; Johnson TM; Fullen DR
Am J Surg Pathol; 2011 Feb; 35(2):243-52. PubMed ID: 21263245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
